Kawamoto H, Uozumi T, Kawamoto K, Arita K, Yano T, Hirohata T
Department of Neurosurgery, Hiroshima University School of Medicine, Japan.
Acta Neurochir (Wien). 1995;136(1-2):37-43. doi: 10.1007/BF01411433.
Pituitary adenomas generally are regarded as benign tumours, but a part of them can invade the cavernous sinus and recur. We examined 43 pituitary adenomas for the following factors: tumour volume, endocrinological function, cavernous sinus invasion, and growth rates examined by using anti-proliferating cell nuclear antigen (PCNA) and MIB1 (a novel anti-Ki-67) as markers. There was significant correlation between PCNA- and MIB1-positive cell rates and PCNA- and MIB1-positive cell rates were higher in the three cases with rapid regrowth than in the other cases. Staining was stronger and more distinct for MIB1 than for anti-PCNA; thus, MIB1-positive cells were easily distinguished by their intense immunoreactivity. MIB1 may be useful for detecting those rare cases with rapid regrowth even when initially regarded as benign tumours. Adenomas with cavernous sinus invasion were significantly larger than those demonstrating no invasion. However, no significant difference was found in the frequency of PCNA- or MIB1-positive cells between adenomas with and without cavernous sinus invasion. These findings suggest that cavernous sinus invasion and growth rate are independent biological factors. Therefore, cavernous sinus invasion may be due to chemical factors produced by the tumour itself rather than as a result of rapid tumour growth.
垂体腺瘤通常被视为良性肿瘤,但其中一部分可侵犯海绵窦并复发。我们对43例垂体腺瘤进行了以下因素的检查:肿瘤体积、内分泌功能、海绵窦侵犯情况,以及使用抗增殖细胞核抗原(PCNA)和MIB1(一种新型抗Ki-67)作为标志物检测的生长速率。PCNA和MIB1阳性细胞率之间存在显著相关性,且在3例快速复发的病例中,PCNA和MIB1阳性细胞率高于其他病例。MIB1的染色比抗PCNA更强且更明显;因此,MIB1阳性细胞因其强烈的免疫反应性而易于区分。MIB1可能有助于检测那些即使最初被视为良性肿瘤但仍有快速复发的罕见病例。侵犯海绵窦的腺瘤明显大于未侵犯的腺瘤。然而,在侵犯和未侵犯海绵窦的腺瘤之间,PCNA或MIB1阳性细胞的频率未发现显著差异。这些发现表明,海绵窦侵犯和生长速率是独立的生物学因素。因此,海绵窦侵犯可能是由于肿瘤自身产生的化学因素,而非肿瘤快速生长的结果。